Protalix BioTherapeutics, Inc. (Amex: PLX) announced today that it has received notice from the U.S. FDA that the FDA's Office ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE